COVID-19 in Patients With Chronic Liver Diseases

ID#: NCT04439084

Age: 18 years - 66+

Gender: All

Recruitment Status: Enrolling by invitation

Start Date: March 06, 2020

End Date: June 01, 2021

Summary: This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Eligibility:

Inclusion Criteria:

- Confirmed diagnosis of COVID-19

- Personal history of either

- Chronic hepatitis C

- Chronic hepatitis B

- Alcoholic liver disease

- Non alcoholic liver disease

- Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis

- Cryptogenic cirrhosis

- Hepatocellular carcinoma

Exclusion Criteria:

- Non-COVID-19 patient